1. Alam R, Verma MK, Verma P. Glycated hemoglobin as a dual biomarker in type 2 diabetes mellitus predicting glycemic control and dyslipidemia risk. Int. J. Life. Sci. Scienti. Res. 2015 Oct;1(2):62-65.
2. Babikr WG, Alshahrani AS, Hamid HG, Abdelraheem AH, Shalayel MH. The correlation of HbA1c with body mass index and HDL-cholesterol in type 2 diabetic patients. Biomed Res. 2016;27(4):1280-83.
3. Vinod MR, Gyawali P, Raut PP, Regmi P, Psd K, Singh DR, Gyawali P. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22(3):375-80.
4. Sarbini D, Huriyati E, Sadewa AH, Wahyuningsih MSH. Correlation Between Lipid Profiles with Pancreatic β- Cell Function in Patients with Type 2 Diabetes Mellitus. 4th International Symposium on Health Research (ISHR 2019). Advances in Health Sciences Research. 2020;22:298-304.
5. Shafique S, Daud Mirza SS, Tabassum S, Faraz N. Frequency of Dyslipidemia In Type 2 Diabetic Patients In Karachi. JBUMDC. 2019;9(2):133-36.